p-quinone methides are the major decomposition products of catechol estrogen o-quinones

Carcinogenesis

Volumn 17, Issue 5, 1996, Pages 925-929

  Bolton, Judy L ^a   Shen, Li ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRONE; CARCINOGEN; CATECHOL ESTROGEN; GLUTATHIONE; QUINONE DERIVATIVE;

ALKYLATION; ARTICLE; BREAST CANCER; CARCINOGENESIS; CONTROLLED STUDY; DECOMPOSITION; ISOMERISM; MACROMOLECULE; MASS SPECTROMETRY; OXIDATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RISK; ULTRAVIOLET SPECTROSCOPY;

ESTROGENS, CATECHOL; GLUTATHIONE; INDOLEQUINONES; INDOLES; QUINONES;

EID: 0029949969     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.5.925     Document Type: Article

References (27)

1. Henderson,B.B., Ross,R. and Berslein,L. (1989) Estrogens as a cause of human cancer. The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res., 48, 246-253.
2. Liehr,J.G. (1990) Genotoxic effects of estrogens. Mutat Res., 238, 269-276.
3. Vogel,V.G., Yeomeans,A. and Higinbotham,E. (1993) Clinical management of women at increased risk for breast cancer. Breast Cancer Res. Treatment, 28, 195-210.
4. Colditz,G.A., Hankinson,S.E., Hunter,D.J., Willett,W.C. Manson,J.E., Stampfer,M.J., Hennekens,C., Rosner,B. and Speizer,F.E. (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl. J. Med., 332, 1589-1593.
5. Davidson,N.E. (1995) Hormone-replacement therapy - breast versus heart versus bone. New Engl. J. Med., 332, 1638 1639.
6. Harris,R.B., Laws,A., Reddy,F.M., King,A. and Haskell,W.L. (1990) Are women using postmenopausal estrogens? A community survey. Am. J. Public Health, 80, 1266 1268.
7. Ball,P. and Knuppen,R. (1980) Catecholoestragens (2- and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endo. Logica, 93, 1-127.
8. Martucci,C.P. and Fishman J. (1993) P450 enzymes of estrogen metabolism. Pharmacol. Ther., 57, 237-254.
9. Liehr,J.G. and Roy,D. (1990) Free radical generation by redox cycling of estrogens. Free Rad. Biol. Med., 8, 415-423.
10. Li,Y., Trush,M.A. and Yager,J.D. (1994) DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. Carcinogenesis, 15, 1421-1427.
11. Liehr,J.G., Hall,E.R., Avitts,T.A., Randerath,E. and Randerath,K. (1987) Localization of estrogen-induced DNA adducts and cytochrome P450 activity at the site of renal carcinogenesis in the hamster kidney. Cancer Res., 47, 2156-2159.
12. Dwivedy,I., Devanesan,P., Cremonesi,P., Rogan,E. and Cavalieri,E. (1992) Synthesis and characterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens. Chem. Res. Toxicol., 5, 828-833.
13. Nelson,S.D., Mitchell,J.R., Dybing,E. and Sasame,H.A. (1976) Cytochrome P450-mediated oxidation of 2-hydroxyestrogens to reactive intermediates. Biochem. Biophys. Res. Commun., 70, 1157-1165.
14. Freyberger,A. and Degen,G.H. (1989) Covalent binding to proteins of reactive intermediates resulting from prostaglandin H synthase-catalyzed oxidation of stilbene and steroid estrogens. J. Biochem. Toxicol., 4, 95-103.
15. Iverson,S.L., Shen,L., Anlar,N. and Bolton,J.L. (1996) Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes. Chem. Res. Toxicol., 9, 492-499.
16. Stubenrauch,G. and Knuppen,R. (1976) Convenient large scale preparation of catechol estrogens. Steroids, 28, 733-741.
17. Bolton,J.L., Valerio,L.G.J. and Thompson,J.A. (1992) The enzymatic formation and chemical reactivity of quinone methides correlate with alkylphenol-induced toxicity in rat hepatocytes. Chem. Res. Toxicol., 5, 816-822.
18. Kalyanaraman,B., Premovic,P.I. and Sealy,R.C. (1987) Semiquinone anion radicals from addition of amino acids, peptides, and proteins to quinones derived from oxidation of catechols and catecholamines: an ESR stabilization study. J. Biol. Chem., 262, 11080-11087.
19. Bolton,J.L., Acay,N.M. and Vukomanovic,V. (1994) Evidence that 4-allylortho-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole. Chem. Res. Toxicol., 7, 443 450.
20. Iverson,S.L., Hu,L.Q., Vukomanovic,V. and Bolton,J.L. (1995) The influence of the para-alkyl substituent on the isomerization of o-quinones to p-quinone methides: potential bioactivation mechanism for catechols. Chem. Res. Toxicol., 8, 537 544.
21. Liehr,J.G., Fang,W.R., Sirbasku,D.A. and Ari-Ulubelen,A. (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem., 24, 353-356.
22. Mills,J.S., Barrera,J., Olivares,E. and Garcia,H. (1960) Steroids. CL. 10b-Halo Steroids. J. Am. Chem. Soc., 82, 5882-5889.
23. Bolton,J.L., Wu,H.M. and Hu,L.Q. (1996) Mechanism of isomerization of 4-propyl-o-quinone to its tautomeric p-quinone methide. Chem. Res. Toxicol., 9, 109-113.
24. Powis,G. (1987) Metabolism and reactions of quinoid anticancer agents. Pharmacol. Ther., 35, 57 162.
25. Abul-Hajj,Y.J., Tabakovic,K. and Tabakovic,I. (1995) An estrogen-nucleic acid adduct. Electroreductive intermolecular coupling of 3,4-estrone-o-quinone and adenine. J. Am. Chem. Soc., 117, 6144-6145.
26. Egholm,M. and Koch,T.H. (1989) Coupling of the anthracycline antitumor drug menogaril to 2′-deoxyguanosine through reductive activation. J. Am. Chem. Soc., 111, 8291 8293.
27. Angle,S.R. and Yang,W. (1992) Nucleophilic addition of 2′-deoxynucleosides to the o-quinone methides 10-(acetyloxy)- and 10-methoxy-3,4-dihydro-9(2H)-anthracenone. J. Org. Chem., 57, 1092-1097.